default author photo

Lewis Au

The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

234

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

Number of pages: 53 Posted: 17 Jun 2019
The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Sequencing Solutions, Institut de Cancérologie de Lorraine - Biopathology Service, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, Royal Marsden Hospital, Royal Marsden Hospital, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Sequencing Solutions, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Royal Marsden NHS Foundation Trust, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics and The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory
Downloads 167 (451,954)

Abstract:

Loading...

Tumor Sequencing, Molecular Profiling, Next Generation Sequencing, Cancer Genetics, Cancer Biomarkers

2.

Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma

Number of pages: 64 Posted: 26 Mar 2021
The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Retroviral Immunology, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Francis Crick Institute - Cancer Dynamics Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Francis Crick Institute - Retroviral Immunology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Biocruces Bizkaia Health Research Institute - Department of Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Cancer Institute - Cancer Research UK Lung Cancer Centre of Excellence, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Renal and Skin Units, University College London - Cancer Immunology Unit, Peter MacCallum Cancer Centre - Division of Research, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Independent, The Francis Crick Institute, University College London - Division of Infection and Immunity, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory and Independent
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

clear cell renal cell carcinoma, nivolumab, immunotherapy, cytotoxicity, TCR clonal maintenance, TCR clonal replacement, human endogenous retrovirus, longitudinal sampling, multiregion sampling, autopsy